GCA
TDOC icon

Genesee Capital Advisors’s Teladoc Health TDOC Stock Holding History

Genesee Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,706
Closed -$216K – 118
2021
Q3 		$216K Buy
+1,706
New +$248K 0.11% 104
2021
Q2 		– Sell
-11,043
Closed -$2.01M – 115
2021
Q1 		$2.01M Buy
11,043
+9,788
+780% +$2.27M 1.19% 33
2020
Q4 		$250K Buy
+1,255
New +$255K 0.16% 73

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Genesee Capital Advisors's TDOC Position: Q4 2021 in Review

Genesee Capital Advisors sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 1,706 shares — an estimated $216K sold.

Genesee Capital Advisors first reported a position in TDOC in Q4 2020 and held it in 3 quarters. The position peaked at $2.01M in Q1 2021. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Genesee Capital Advisors reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Genesee Capital Advisors sold 1,706 Teladoc Health shares in Q4 2021, an estimated $216K.
  • Genesee Capital Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 3 quarters.
  • Genesee Capital Advisors's Teladoc Health position peaked at $2.01M in Q1 2021.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Genesee Capital Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.